Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.
He also found that investing in profitable companies performs as well as investing in cheap stocks. Novy-Marx defines profitability differently than most. He uses gross profitability, not line ...